Equities

Vicarious Surgical Inc

RBOT:NYQ

Vicarious Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)7.33
  • Today's Change0.42 / 6.08%
  • Shares traded33.52k
  • 1 Year change-87.07%
  • Beta1.1450
Data delayed at least 15 minutes, as of Jul 05 2024 21:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.2 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

  • Revenue in USD (TTM)0.00
  • Net income in USD-61.15m
  • Incorporated2021
  • Employees131.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Icecure Medical Ltd3.26m-14.49m35.44m71.00--3.05--10.87-0.3157-0.31570.0710.24270.1520.79921.7545,943.66-67.52-54.89-84.42-68.6638.2949.87-444.30-313.192.88--0.00--4.6723.5013.70--48.10--
DarioHealth Corp19.04m-59.90m35.61m276.00--0.449--1.87-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
Holdco Nuvo Group DG Ltd0.00-3.49m35.92m----0.9932-----0.3581-0.35810.001.090.00-------2.34---2.40--------------0.00-------255.01------
Owlet Inc58.02m-23.69m36.37m76.00------0.6269-2.87-2.876.71-2.421.062.944.30763,473.70-32.36---181.41--43.05---30.61--0.8182-43.37-----21.95--52.74------
electroCore, Inc.18.69m-16.47m37.54m68.00--8.35--2.01-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Precision Optics Corporation Inc19.41m-1.64m37.81m84.00--3.36--1.95-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
BioNano Genomics Inc37.47m-226.79m38.16m344.00--0.3968--1.02-6.15-6.150.9421.440.16651.034.97108,924.40-100.76-56.82-128.31-67.8327.5425.38-605.26-505.761.13-83.420.0444--29.9024.65-75.34--38.51--
BioRegenx Inc634.81k-727.95k38.26m10.00--2.25--60.27-0.001-0.0010.00160.01780.0617----63,481.00-7.07---8.46--74.90---114.67--0.1547-8.800.0977---47.25---629.37------
Lucid Diagnostics Inc2.98m-54.53m39.15m70.00------13.13-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
Co-Diagnostics Inc6.68m-38.89m40.04m155.00--0.5110--6.00-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
Vicarious Surgical Inc0.00-61.15m40.63m131.00--2.04-----11.78-11.780.003.380.00----0.00-54.03---56.98--------------0.00-------1,478.15------
IR-Med Inc0.00-4.22m42.41m6.00---------0.0608-0.06080.00-0.00120.00----0.00-285.64---463.30--------------2.16-------3.70------
United Health Products Inc0.00-1.93m44.01m6.00---------0.008-0.0080.00-0.00730.000.00--0.00-719.43-6,446.86------53.19---132,561.200.0483-15.60-----100.00---55.45------
Modular Medical Inc0.00-17.47m45.55m39.00--3.94-----0.795-0.7950.000.35530.00----0.00-165.97-187.51-187.67-234.72------------0.00-------25.87--85.63--
Vaso Corp80.54m3.18m45.58m300.0012.561.7811.150.5660.02070.02070.45890.14591.1620.037.77268,470.004.577.607.4416.6261.8358.393.955.821.37--0.0091--2.181.84-57.46---22.33--
Envoy Medical Inc297.00k-22.43m45.86m34.00------154.42-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
Data as of Jul 05 2024. Currency figures normalised to Vicarious Surgical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.